Loading clinical trials...
Loading clinical trials...
A Pilot Study of 18F FLT PET/CT in Evaluating Early Response to Anti-Proliferative Therapies in Non Small Cell Lung Cancer and Thymic Tumors
Conditions
Interventions
3'-deoxy-3'-18F fluorothymidine (FLT)
PET/CT scan
Start Date
May 10, 2012
Primary Completion Date
December 10, 2012
Completion Date
December 10, 2012
Last Updated
July 5, 2018
NCT06667908
NCT04165798
NCT06875310
NCT07046923
NCT06885697
NCT07222566
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions